![]() Decibel Therapeutics Decibel Therapeutics is a biotechnology company that discovers and develops transformative treatments to restore and improve hearing and balance. | ![]() ReShape Lifesciences ReShape Lifesciences, a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders. | ![]() ElectroCore ElectroCore develops neuromodulation therapies for the non-invasive treatment of diseases and disorders. | |||
Founding Date | Founding Date N/A | Founding Date 2015 | Founding Date 2002 | Founding Date 2002 | Founding Date 2005 |
Type | Type Private | Type Subsidiary | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Dublin, IE HQ Dublin, IE | Locations Boston, US HQ | Locations San Clemente, US HQ San Clemente, US | Locations San Carlos, US HQ | Locations Rockaway, US HQ Parksville, CA Geretsried, DE Hamburg, DE Yeadon, GB Bernards, US |
Employees | Employees 838% increase | Employees 6810% increase | Employees 4348% decrease | Employees 2713% increase | Employees 5144% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 3 m | Valuation ($) 8.5 m | Valuation ($) 71.2 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $11.3m (FY, 2020) | Revenue (est.) N/A | Revenue (est.) $32m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $5m (FY, 2020) | Cost of goods N/A | Cost of goods $4.2m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit $6.3m (FY, 2020) | Gross profit N/A | Gross profit $27.8m (FY, 2025) |
Net income | Net income N/A | Net income ($63m) (FY, 2022) | Net income ($21.6m) (FY, 2020) | Net income ($8.2m) (FY, 2025) | Net income ($14m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 7.5m | Total funding raised $ 189m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 127m |

Decibel Therapeutics is a biotechnology company that discovers and develops transformative treatments to restore and improve hearing and balance.
View company
ReShape Lifesciences, a medical device company, focuses on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases, and other gastrointestinal disorders.
View company
BioCardia is a clinical-stage regenerative medicine company.
View company
ElectroCore develops neuromodulation therapies for the non-invasive treatment of diseases and disorders.
View company